Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression

被引:193
作者
Wagner, BL
Valledor, AF
Shao, G
Daige, CL
Bischoff, ED
Petrowski, M
Jepsen, K
Baek, SH
Heyman, RA
Rosenfeld, MG
Schulman, IG
Glass, CK
机构
[1] X Ceptor Therapeut Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, Div Cellular & Mol Med, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA
关键词
D O I
10.1128/MCB.23.16.5780-5789.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver X receptors (LXRs) regulate the expression of genes involved in cholesterol and fatty acid homeostasis, including the genes for ATP-binding cassette transporter A1 (ABCA1) and sterol response element binding protein 1 (SREBP1). Loss of LXR leads to derepression of the ABCA1 gene in macrophages and the intestine, while the SREBP1c gene remains transcriptionally silent. Here we report that high-density-lipoprotein (HDL) cholesterol levels are increased in LXR-deficient mice, suggesting that derepression of ABCA1 and possibly other LXR target genes in selected tissues is sufficient to result in enhanced HDL biogenesis at the whole-body level. We provide several independent lines of evidence indicating that the repressive actions of LXRs are dependent on interactions with the nuclear receptor corepressor (NCoR) and the silencing mediator of retinoic acid and thyroid hormone receptors (SMRT). While dissociation of NCoR and SMRT results in derepression of the ABCA1 gene in macrophages, it is not sufficient for derepression of the SREBP1c gene. These findings reveal differential requirements for corepressors in the regulation of genes involved in cholesterol and fatty acid homeostasis and raise the possibility that these interactions may be exploited to develop synthetic ligands that selectively modulate LXR actions in vivo.
引用
收藏
页码:5780 / 5789
页数:10
相关论文
共 42 条
  • [1] TREATMENT OF SEVERE HYPERCHOLESTEROLEMIA IN APOLIPOPROTEIN E-DEFICIENT MICE BY BONE-MARROW TRANSPLANTATION
    BOISVERT, WA
    SPANGENBERG, J
    CURTISS, LK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) : 1118 - 1124
  • [2] A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
    Brown, MS
    Goldstein, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) : 11041 - 11048
  • [3] EVIDENCE FOR A GAMMA-INTERFERON RECEPTOR THAT REGULATES MACROPHAGE TUMORICIDAL ACTIVITY
    CELADA, A
    GRAY, PW
    RINDERKNECHT, E
    SCHREIBER, RD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) : 55 - 74
  • [4] A TRANSCRIPTIONAL CO-REPRESSOR THAT INTERACTS WITH NUCLEAR HORMONE RECEPTORS
    CHEN, JD
    EVANS, RM
    [J]. NATURE, 1995, 377 (6548) : 454 - 457
  • [5] Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
    Claudel, T
    Leibowitz, MD
    Fiévet, C
    Tailleux, A
    Wagner, B
    Repa, JJ
    Torpier, G
    Lobaccaro, JM
    Paterniti, JR
    Mangelsdorf, DJ
    Heyman, RA
    Auwerx, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) : 2610 - 2615
  • [6] Costet P, 2000, J BIOL CHEM, V275, P28240
  • [7] Co-regulator recruitment and the mechanism of retinoic acid receptor synergy
    Germain, P
    Iyer, J
    Zechel, C
    Gronemeyer, H
    [J]. NATURE, 2002, 415 (6868) : 187 - 192
  • [8] Glass CK, 2000, GENE DEV, V14, P121
  • [9] Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels
    Haghpassand, M
    Bourassa, PAK
    Francone, OL
    Aiello, RJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) : 1315 - 1320
  • [10] Hecht A, 1999, METHOD ENZYMOL, V304, P399